{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/entity/PTCT/timeline","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://api.ai-analytics.org/license","usage_info":"https://api.ai-analytics.org/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-22T11:59:43.360Z","methodology_url":"https://api.ai-analytics.org/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":117,"canonical_name":"PTC THERAPEUTICS, INC.","cik":"0001070081","uei":null,"lei":null,"duns":null,"ticker":"PTCT"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","open.payments","dol.form5500","hud.housing","irs.bmf"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":131,"clinical":3,"open":1},"count":100,"timeline":[{"ts":"2026-09-11","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-09-11","url_slug":"/sec/cik-0001070081/4/0001288952-26-000008","accession_number":"0001288952-26-000008","importance":30},{"ts":"2026-09-10","kind":"sec.insider.s","reporter":"SCHMERTZLER MICHAEL","title":"","shares":10000,"price_per_share":67.34,"usd_value":673400,"security_title":"Common Stock","importance":35.6734},{"ts":"2026-09-09","kind":"sec.insider.s","reporter":"SCHMERTZLER MICHAEL","title":"","shares":9428,"price_per_share":67.79,"usd_value":639124,"security_title":"Common Stock","importance":35.63912412},{"ts":"2026-09-09","kind":"sec.insider.s","reporter":"SCHMERTZLER MICHAEL","title":"","shares":572,"price_per_share":68.67,"usd_value":39279,"security_title":"Common Stock","importance":35.03927924},{"ts":"2026-07-16","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-07-16","url_slug":"/sec/cik-0001070081/4/0001984065-26-000008","accession_number":"0001984065-26-000008","importance":30},{"ts":"2026-07-14","kind":"sec.form144","reporter":"Gravier Pierre","title":"Officer","shares":3494,"usd_value":280733,"security_title":"Common","approx_sale_date":"2026-07-14","accession_number":"0001959173-26-005220","importance":40.056146554},{"ts":"2026-07-14","kind":"sec.insider.s","reporter":"Gravier Pierre","title":"CHIEF FINANCIAL OFFICER","shares":3494,"price_per_share":80.35,"usd_value":280743,"security_title":"Common Stock","importance":35.2807429},{"ts":"2026-07-14","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-07-14","url_slug":"/sec/cik-0001070081/144/0001959173-26-005220","accession_number":"0001959173-26-005220","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-07-13","url_slug":"/sec/cik-0001070081/4/0001578850-26-000023","accession_number":"0001578850-26-000023","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-07-13","url_slug":"/sec/cik-0001070081/4/0001866044-26-000005","accession_number":"0001866044-26-000005","importance":30},{"ts":"2026-07-09","kind":"sec.form144","reporter":"Smith Mary L.","title":"Director","shares":15834,"usd_value":1425060,"security_title":"Common","approx_sale_date":"2026-07-09","accession_number":"0001959173-26-005172","importance":40.285012},{"ts":"2026-07-09","kind":"sec.form144","reporter":"Almstead Neil Gregory","title":"Officer","shares":2464,"usd_value":222368,"security_title":"Common","approx_sale_date":"2026-07-09","accession_number":"0001959173-26-005179","importance":40.044473646},{"ts":"2026-07-09","kind":"sec.insider.s","reporter":"Smith Mary L.","title":"","shares":10000,"price_per_share":90,"usd_value":900000,"security_title":"Common Stock","importance":35.9},{"ts":"2026-07-09","kind":"sec.insider.s","reporter":"Smith Mary L.","title":"","shares":5834,"price_per_share":90,"usd_value":525060,"security_title":"Common Stock","importance":35.52506},{"ts":"2026-07-09","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":2464,"price_per_share":90.25,"usd_value":222376,"security_title":"Common Stock","importance":35.222376},{"ts":"2026-07-09","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-07-09","url_slug":"/sec/cik-0001070081/144/0001959173-26-005172","accession_number":"0001959173-26-005172","importance":30},{"ts":"2026-07-09","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-07-09","url_slug":"/sec/cik-0001070081/144/0001959173-26-005179","accession_number":"0001959173-26-005179","importance":30},{"ts":"2026-07-09","kind":"sec.insider.m","reporter":"Smith Mary L.","title":"","shares":10000,"price_per_share":42.95,"usd_value":429500,"security_title":"Common Stock","importance":15.4295},{"ts":"2026-07-09","kind":"sec.insider.m","reporter":"Smith Mary L.","title":"","shares":5834,"price_per_share":42.95,"usd_value":250570,"security_title":"Common Stock","importance":15.2505703},{"ts":"2026-07-09","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":2464,"price_per_share":46.54,"usd_value":114675,"security_title":"Common Stock","importance":15.11467456},{"ts":"2026-07-08","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-07-08","url_slug":"/sec/cik-0001070081/4/0001578852-26-000020","accession_number":"0001578852-26-000020","importance":30},{"ts":"2026-07-08","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-07-08","url_slug":"/sec/cik-0001070081/4/0001578850-26-000021","accession_number":"0001578850-26-000021","importance":30},{"ts":"2026-07-07","kind":"sec.form144","reporter":"Almstead Neil Gregory","title":"Officer","shares":24613,"usd_value":2187696,"security_title":"Common","approx_sale_date":"2026-07-07","accession_number":"0001959173-26-005150","importance":40.437539122},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":11369,"price_per_share":89.03,"usd_value":1012182,"security_title":"Common Stock","importance":36.01218207},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":9288,"price_per_share":89.44,"usd_value":830719,"security_title":"Common Stock","importance":35.83071872},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":3956,"price_per_share":87.17,"usd_value":344845,"security_title":"Common Stock","importance":35.34484452},{"ts":"2026-07-07","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-07-07","url_slug":"/sec/cik-0001070081/144/0001959173-26-005150","accession_number":"0001959173-26-005150","importance":30},{"ts":"2026-07-07","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":24613,"price_per_share":39.42,"usd_value":970244,"security_title":"Common Stock","importance":15.97024446},{"ts":"2026-07-06","kind":"sec.form144","reporter":"Almstead Neil Gregory","title":"Officer","shares":22161,"usd_value":1905797,"security_title":"Common","approx_sale_date":"2026-07-06","accession_number":"0001959173-26-005117","importance":40.381159486},{"ts":"2026-07-06","kind":"sec.form144","reporter":"Boulding Mark Elliott","title":"Officer","shares":5079,"usd_value":427322,"security_title":"Common","approx_sale_date":"2026-07-06","accession_number":"0001959173-26-005114","importance":40.085464334},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":10090,"price_per_share":86.32,"usd_value":870969,"security_title":"Common Stock","importance":35.8709688},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":8786,"price_per_share":85.35,"usd_value":749885,"security_title":"Common Stock","importance":35.7498851},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":2474,"price_per_share":87.03,"usd_value":215312,"security_title":"Common Stock","importance":35.21531222},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":1036,"price_per_share":84.41,"usd_value":87449,"security_title":"Common Stock","importance":35.08744876},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":833,"price_per_share":84.41,"usd_value":70314,"security_title":"Common Stock","importance":35.07031353},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":745,"price_per_share":86.38,"usd_value":64353,"security_title":"Common Stock","importance":35.0643531},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":645,"price_per_share":85.84,"usd_value":55367,"security_title":"Common Stock","importance":35.0553668},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":601,"price_per_share":86.38,"usd_value":51914,"security_title":"Common Stock","importance":35.05191438},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":519,"price_per_share":85.84,"usd_value":44551,"security_title":"Common Stock","importance":35.04455096},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":426,"price_per_share":85.28,"usd_value":36329,"security_title":"Common Stock","importance":35.03632928},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":385,"price_per_share":86.34,"usd_value":33241,"security_title":"Common Stock","importance":35.0332409},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":387,"price_per_share":83.1,"usd_value":32160,"security_title":"Common Stock","importance":35.0321597},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":313,"price_per_share":83.1,"usd_value":26010,"security_title":"Common Stock","importance":35.0260103},{"ts":"2026-07-06","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-07-06","url_slug":"/sec/cik-0001070081/144/0001959173-26-005114","accession_number":"0001959173-26-005114","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-07-06","url_slug":"/sec/cik-0001070081/144/0001959173-26-005117","accession_number":"0001959173-26-005117","importance":30},{"ts":"2026-07-06","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":18876,"price_per_share":38.1,"usd_value":719176,"security_title":"Common Stock","importance":15.7191756},{"ts":"2026-07-06","kind":"sec.insider.m","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":2813,"price_per_share":46.54,"usd_value":130917,"security_title":"Common Stock","importance":15.13091702},{"ts":"2026-07-06","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":2474,"price_per_share":39.42,"usd_value":97525,"security_title":"Common Stock","importance":15.09752508},{"ts":"2026-07-06","kind":"sec.insider.m","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":2266,"price_per_share":39.42,"usd_value":89326,"security_title":"Common Stock","importance":15.08932572},{"ts":"2026-07-06","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":811,"price_per_share":38.1,"usd_value":30899,"security_title":"Common Stock","importance":15.0308991},{"ts":"2026-06-30","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-06-30","url_slug":"/sec/cik-0001070081/4/0001578850-26-000019","accession_number":"0001578850-26-000019","importance":30},{"ts":"2026-06-26","kind":"sec.form144","reporter":"Almstead Neil Gregory","title":"Officer","shares":8130,"usd_value":693146,"security_title":"Common","approx_sale_date":"2026-06-26","accession_number":"0001959173-26-004919","importance":40.13862921},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":7718,"price_per_share":85.26,"usd_value":658037,"security_title":"Common Stock","importance":35.65803668},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":412,"price_per_share":85.23,"usd_value":35115,"security_title":"Common Stock","importance":35.03511476},{"ts":"2026-06-26","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-06-26","url_slug":"/sec/cik-0001070081/144/0001959173-26-004919","accession_number":"0001959173-26-004919","importance":30},{"ts":"2026-06-26","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-06-26","url_slug":"/sec/cik-0001070081/4/0001578850-26-000017","accession_number":"0001578850-26-000017","importance":30},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":7718,"price_per_share":38.1,"usd_value":294056,"security_title":"Common Stock","importance":15.2940558},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":412,"price_per_share":38.1,"usd_value":15697,"security_title":"Common Stock","importance":15.0156972},{"ts":"2026-06-25","kind":"sec.form144","reporter":"Almstead Neil Gregory","title":"Officer","shares":20960,"usd_value":1801869,"security_title":"Common","approx_sale_date":"2026-06-25","accession_number":"0001959173-26-004899","importance":40.36037388},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":11337,"price_per_share":86.51,"usd_value":980764,"security_title":"Common Stock","importance":35.98076387},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":8522,"price_per_share":85.26,"usd_value":726586,"security_title":"Common Stock","importance":35.72658572},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":582,"price_per_share":85.24,"usd_value":49610,"security_title":"Common Stock","importance":35.04960968},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":419,"price_per_share":86.39,"usd_value":36197,"security_title":"Common Stock","importance":35.03619741},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":100,"price_per_share":87,"usd_value":8700,"security_title":"Common Stock","importance":35.0087},{"ts":"2026-06-25","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-06-25","url_slug":"/sec/cik-0001070081/144/0001959173-26-004899","accession_number":"0001959173-26-004899","importance":30},{"ts":"2026-06-25","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":19859,"price_per_share":38.1,"usd_value":756628,"security_title":"Common Stock","importance":15.7566279},{"ts":"2026-06-25","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":1001,"price_per_share":38.1,"usd_value":38138,"security_title":"Common Stock","importance":15.0381381},{"ts":"2026-06-25","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":100,"price_per_share":39.42,"usd_value":3942,"security_title":"Common Stock","importance":15.003942},{"ts":"2026-06-24","kind":"sec.form144","reporter":"Almstead Neil Gregory","title":"Officer","shares":5323,"usd_value":452592,"security_title":"Common","approx_sale_date":"2026-06-24","accession_number":"0001959173-26-004862","importance":40.090518316},{"ts":"2026-06-24","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":4922,"price_per_share":85.03,"usd_value":418518,"security_title":"Common Stock","importance":35.41851766},{"ts":"2026-06-24","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":401,"price_per_share":85.01,"usd_value":34089,"security_title":"Common Stock","importance":35.03408901},{"ts":"2026-06-24","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-06-24","url_slug":"/sec/cik-0001070081/144/0001959173-26-004862","accession_number":"0001959173-26-004862","importance":30},{"ts":"2026-06-24","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-06-24","url_slug":"/sec/cik-0001070081/4/0001578850-26-000014","accession_number":"0001578850-26-000014","importance":30},{"ts":"2026-06-24","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":4922,"price_per_share":38.1,"usd_value":187528,"security_title":"Common Stock","importance":15.1875282},{"ts":"2026-06-24","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":401,"price_per_share":38.1,"usd_value":15278,"security_title":"Common Stock","importance":15.0152781},{"ts":"2026-06-22","kind":"sec.form144","reporter":"Almstead Neil Gregory","title":"Officer","shares":23749,"usd_value":1921433,"security_title":"Common","approx_sale_date":"2026-06-22","accession_number":"0001959173-26-004813","importance":40.384286518},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":12130,"price_per_share":80.61,"usd_value":977799,"security_title":"Common Stock","importance":35.9777993},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":11619,"price_per_share":81.21,"usd_value":943579,"security_title":"Common Stock","importance":35.94357899},{"ts":"2026-06-22","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-06-22","url_slug":"/sec/cik-0001070081/144/0001959173-26-004813","accession_number":"0001959173-26-004813","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-06-22","url_slug":"/sec/cik-0001070081/4/0001578852-26-000018","accession_number":"0001578852-26-000018","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-06-22","url_slug":"/sec/cik-0001070081/4/0001707685-26-000010","accession_number":"0001707685-26-000010","importance":30},{"ts":"2026-06-22","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":23749,"price_per_share":25.69,"usd_value":610112,"security_title":"Common Stock","importance":15.61011181},{"ts":"2026-06-18","kind":"sec.filing","form_type":"8-K","title":"8-K — PTC THERAPEUTICS, INC. — 2026-06-18","url_slug":"/sec/cik-0001070081/8-k/0001104659-26-075731","accession_number":"0001104659-26-075731","importance":35},{"ts":"2026-06-17","kind":"sec.form144","reporter":"Utter Christine Marie","title":"Officer","shares":19686,"usd_value":1487474,"security_title":"Common","approx_sale_date":"2026-06-17","accession_number":"0001959173-26-004724","importance":40.297494832},{"ts":"2026-06-17","kind":"sec.form144","reporter":"Boulding Mark Elliott","title":"Officer","shares":10522,"usd_value":827607,"security_title":"Common","approx_sale_date":"2026-06-17","accession_number":"0001959173-26-004755","importance":40.165521386},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Utter Christine Marie","title":"SVP, CHIEF ACCOUNTING OFFICER","shares":19686,"price_per_share":75.56,"usd_value":1487474,"security_title":"Common Stock","importance":36.48747416},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":6600,"price_per_share":78.5,"usd_value":518100,"security_title":"Common Stock","importance":35.5181},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":1850,"price_per_share":79.24,"usd_value":146594,"security_title":"Common Stock","importance":35.146594},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":1703,"price_per_share":78.5,"usd_value":133686,"security_title":"Common Stock","importance":35.1336855},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":309,"price_per_share":79.25,"usd_value":24488,"security_title":"Common Stock","importance":35.02448825},{"ts":"2026-06-17","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-06-17","url_slug":"/sec/cik-0001070081/144/0001959173-26-004724","accession_number":"0001959173-26-004724","importance":30},{"ts":"2026-06-17","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-06-17","url_slug":"/sec/cik-0001070081/144/0001959173-26-004755","accession_number":"0001959173-26-004755","importance":30},{"ts":"2026-06-17","kind":"sec.insider.m","reporter":"Utter Christine Marie","title":"SVP, CHIEF ACCOUNTING OFFICER","shares":19686,"price_per_share":25.69,"usd_value":505733,"security_title":"Common Stock","importance":15.50573334},{"ts":"2026-06-17","kind":"sec.insider.m","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":8510,"price_per_share":46.54,"usd_value":396055,"security_title":"Common Stock","importance":15.3960554},{"ts":"2026-06-17","kind":"sec.insider.m","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":2012,"price_per_share":46.54,"usd_value":93638,"security_title":"Common Stock","importance":15.09363848},{"ts":"2026-06-16","kind":"sec.filing","form_type":"8-K","title":"8-K — PTC THERAPEUTICS, INC. — 2026-06-16","url_slug":"/sec/cik-0001070081/8-k/0001104659-26-074292","accession_number":"0001104659-26-074292","importance":35},{"ts":"2026-06-12","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-06-12","url_slug":"/sec/cik-0001070081/4/0001323212-26-000010","accession_number":"0001323212-26-000010","importance":30},{"ts":"2026-06-10","kind":"sec.form144","reporter":"Pauwels Eric","title":"Officer","shares":21277,"usd_value":1595775,"security_title":"Common","approx_sale_date":"2026-06-10","accession_number":"0001959173-26-004512","importance":40.319155},{"ts":"2026-06-10","kind":"sec.insider.s","reporter":"Pauwels Eric","title":"CHIEF BUSINESS OFFICER","shares":17566,"price_per_share":75,"usd_value":1317450,"security_title":"Common Stock","importance":36.31745},{"ts":"2026-06-10","kind":"sec.insider.s","reporter":"Pauwels Eric","title":"CHIEF BUSINESS OFFICER","shares":3711,"price_per_share":75,"usd_value":278325,"security_title":"Common Stock","importance":35.278325}]}